Diego Albrecht
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
Papers in
-
- Heart Failure Treatment and Management 8
- Renin-Angiotensin System Studies 1
-
- Receptor Mechanisms and Signaling 5
- Co-authors
- Anja Schweizer (1 shared paper)S. Dejager (1 shared paper)Michelle A. Baron (1 shared paper)Vivian Fonseca (1 shared paper)Parasar Pal (7 shared papers)Thomas Langenickel (8 shared papers)Surya Ayalasomayajula (5 shared papers)Marcus May (3 shared papers)
- Journals
- Hypertension (3 papers)European Heart Journal (2 papers)Circulation (1 paper)Clinical Pharmacology & Therapeutics (1 paper)Xenobiotica (1 paper)
- Partner nations
- SwitzerlandIndiaGermany
In The Last Decade
Diego Albrecht
16 papers receiving 714 citations
Peers
Comparison fields: 5 of 61
- Endocrinology, Diabetes and Metabolism 376
- Cardiology and Cardiovascular Medicine 285
- Surgery 125
- Pharmacology 42
- Oncology 64
Countries citing papers authored by Diego Albrecht
This map shows the geographic impact of Diego Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diego Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diego Albrecht more than expected).
Fields of papers citing papers by Diego Albrecht
This network shows the impact of papers produced by Diego Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diego Albrecht. The network helps show where Diego Albrecht may publish in the future.
Co-authors
The 25 scholars most cited alongside Diego Albrecht, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 317 | |
| 2 | 2017 | 118 | |
| 3 | 2016 | 92 | |
| 4 | 2016 | 66 | |
| 5 | 2017 | 32 | |
| 6 | 2016 | 28 | |
| 7 | 2016 | 28 | |
| 8 | 1997 | 9 | |
| 9 | 2018 | 9 | |
| 10 | 2016 | 9 | |
| 11 | Natriuretic peptide inhibition in the presence of angioten-sin receptor blockade following short-term treatment with LCZ 696 in heart failure patients: effect on ANP, BNP, NT-proBNP and cGMP | 2011 | 6 |
| 12 | Abstract 19378: First Experience with Concomitant AT1 and Neprilysin (NEP 24.11) Inhibition with LCZ696 in Patients with Chronic Heart Failure | 2010 | 4 |
| 13 | 2013 | 4 | |
| 14 | 2012 | 4 | |
| 15 | 2013 | 3 | |
| 16 | [Aescin for the treatment of edema in urology]. | 1968 | 1 |
| 17 | 2013 | 0 |
About Diego Albrecht
Diego Albrecht is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pharmacology, Endocrinology, Diabetes and Metabolism and Complementary and alternative medicine, having authored 17 papers that have together received 730 indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (8 papers), Receptor Mechanisms and Signaling (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Hormonal Regulation and Hypertension (3 papers), Eicosanoids and Hypertension Pharmacology (1 paper), Cardiovascular and exercise physiology (1 paper), Diet and metabolism studies (1 paper) and Renin-Angiotensin System Studies (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (376 citations), Cardiology and Cardiovascular Medicine (285 citations), Surgery (125 citations), Pharmacology (42 citations) and Oncology (64 citations). Diego Albrecht has collaborated with scholars based in Switzerland, India and Germany. Frequent co-authors include Anja Schweizer, S. Dejager, Michelle A. Baron, Vivian Fonseca, Parasar Pal, Thomas Langenickel, Surya Ayalasomayajula, Marcus May, Stefan Engeli and Jens Jordan. Their work appears in journals such as Hypertension, European Heart Journal, Circulation, Clinical Pharmacology & Therapeutics and Xenobiotica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.